image
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 83.45
-5.11 %
$ 7.22 B
Market Cap
73.58
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one HQY stock under the worst case scenario is HIDDEN Compared to the current market price of 83.5 USD, HealthEquity, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one HQY stock under the base case scenario is HIDDEN Compared to the current market price of 83.5 USD, HealthEquity, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one HQY stock under the best case scenario is HIDDEN Compared to the current market price of 83.5 USD, HealthEquity, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart HQY

image
$115.0$115.0$110.0$110.0$105.0$105.0$100.0$100.0$95.0$95.0$90.0$90.0$85.0$85.0$80.0$80.0$75.0$75.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
1.2 B REVENUE
20.03%
162 M OPERATING INCOME
26.69%
96.7 M NET INCOME
73.58%
340 M OPERATING CASH FLOW
39.96%
-505 M INVESTING CASH FLOW
-997.05%
57.6 M FINANCING CASH FLOW
222.38%
312 M REVENUE
3.79%
42.2 M OPERATING INCOME
114.78%
26.4 M NET INCOME
362.30%
75.7 M OPERATING CASH FLOW
-16.35%
-13.6 M INVESTING CASH FLOW
-5.38%
-88.4 M FINANCING CASH FLOW
-7.27%
Balance Sheet HealthEquity, Inc.
image
Current Assets 478 M
Cash & Short-Term Investments 296 M
Receivables 118 M
Other Current Assets 63.8 M
Non-Current Assets 2.97 B
Long-Term Investments 0
PP&E 46.4 M
Other Non-Current Assets 2.92 B
8.58 %3.42 %84.80 %Total Assets$3.4b
Current Liabilities 156 M
Accounts Payable 14.4 M
Short-Term Debt 10 M
Other Current Liabilities 132 M
Non-Current Liabilities 1.02 B
Long-Term Debt 84.4 M
Other Non-Current Liabilities 937 M
11.21 %7.17 %79.55 %Total Liabilities$1.2b
EFFICIENCY
Earnings Waterfall HealthEquity, Inc.
image
Revenue 1.2 B
Cost Of Revenue 423 M
Gross Profit 777 M
Operating Expenses 615 M
Operating Income 162 M
Other Expenses 65.6 M
Net Income 96.7 M
1b1b1b1b800m800m600m600m400m400m200m200m001b(423m)777m(615m)162m(66m)97mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
64.78% GROSS MARGIN
64.78%
13.53% OPERATING MARGIN
13.53%
8.06% NET MARGIN
8.06%
4.57% ROE
4.57%
2.80% ROA
2.80%
4.10% ROIC
4.10%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis HealthEquity, Inc.
image
350m350m300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 96.7 M
Depreciation & Amortization 162 M
Capital Expenditures -2.08 M
Stock-Based Compensation 96.4 M
Change in Working Capital -6.53 M
Others 1.34 M
Free Cash Flow 338 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets HealthEquity, Inc.
image
Wall Street analysts predict an average 1-year price target for HQY of $107 , with forecasts ranging from a low of $100 to a high of $115 .
HQY Lowest Price Target Wall Street Target
100 USD 19.83%
HQY Average Price Target Wall Street Target
107 USD 27.69%
HQY Highest Price Target Wall Street Target
115 USD 37.81%
Price
Max Price Target
Min Price Target
Average Price Target
1151151101101051051001009595909085858080757570706565Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 4
6. Ownership
Insider Ownership HealthEquity, Inc.
image
Sold
0-3 MONTHS
1.78 M USD 2
3-6 MONTHS
4.11 M USD 5
6-9 MONTHS
4.06 M USD 4
9-12 MONTHS
11.4 M USD 4
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY NEW YORK , April 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 1 week ago
HealthEquity, Inc. Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. globenewswire.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. globenewswire.com - 1 week ago
Rosen Law Firm Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY NEW YORK , April 21, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. So What: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. prnewswire.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY NEW YORK CITY, NY / ACCESS Newswire / April 20, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY NEW YORK, NY / ACCESS Newswire / April 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 2 weeks ago
HealthEquity, Inc. Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. globenewswire.com - 2 weeks ago
MD or HQY: Which Is the Better Value Stock Right Now? Investors interested in Medical Services stocks are likely familiar with Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors? zacks.com - 2 weeks ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY NEW YORK CITY, NY / ACCESS Newswire / April 17, 2025 / WHY: New York, N.Y., April 17, 2025. accessnewswire.com - 2 weeks ago
Why Is HealthEquity (HQY) Down 2.2% Since Last Earnings Report? HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? zacks.com - 2 weeks ago
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY NEW YORK CITY, NY / ACCESS Newswire / April 16, 2025 / WHY: New York, N.Y., April 16, 2025. accessnewswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY NEW YORK CITY, NY / ACCESS Newswire / April 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 2 weeks ago
8. Profile Summary

HealthEquity, Inc. HQY

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 7.22 B
Dividend Yield 0.00%
Description HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.
Contact 15 West Scenic Pointe Drive, Draper, UT, 84020 https://www.healthequity.com
IPO Date July 31, 2014
Employees 3105
Officers Ms. Tia Padia Executive Vice President & Chief Marketing Officer Mr. James M. Lucania Chief Financial Officer & Executive Vice President Mr. Delano Ladd J.D. Executive Vice President, General Counsel & Secretary Mr. Scott R. Cutler J.D. Chief Executive Officer, President & Director Dr. Stephen D. Neeleman Founder & Vice Chairman Mr. Steve Lindsay Executive Vice President of Sales & Relationship Management Mr. Brad Bennion Executive Vice President of Corporate Development & Strategy Mr. Richard Putnam Vice President of Investor Relations Mr. Jon Kessler Director & Special Advisor Mr. Elimelech Rosner Executive Vice President & Chief Technology Officer